Location History:
- Guangdong, CN (2013)
- Shenzhen, CN (2014)
Company Filing History:
1 out of 1 
1 out of 1 Years Active: 2013-2014
Title: Weizhen Zeng: Innovator in Anticoagulant Research
Introduction
Weizhen Zeng is an accomplished inventor based in Shenzhen, China. His notable contributions to the field of pharmaceutical sciences are evidenced by his two patents, focused on innovations that have the potential to advance treatment options for thrombotic diseases.
Latest Patents
Zeng's latest patents include a depolymerized glycosaminoglycan, denoted as dTHG, which boasts a weight average molecular weight of approximately 8000–20000 Da. This compound is derived from a complex of monosaccharides, including acetylgalactosamine (GalNAc), glucuronic acid (GlcUA), and fucose (Fuc), in specific molar ratios that enhance its therapeutic potential. The dTHG acts as a potent endogenous inhibitor of factor X, exhibiting significant anticoagulant and antithrombotic activity. This innovation holds promise for the prevention and treatment of thrombotic diseases. Additionally, Zeng developed a novel crystalline form of 3,4',5-trihydroxy-stilbene-3-β-D-glucoside (polydatin). This form exhibits a stable crystalline morphology, defined melting point, and good chemical stability—features that significantly improve the efficiency of drug formulation and production.
Career Highlights
Throughout his career, Zeng has made strides in pharmaceutical research, working primarily with Shenzhen Neptunus Pharmaceutical Co., Ltd. and Shenzhen Neptunus Pharmaceutical Holdings Co., Ltd. His dedication to research and innovation has led to the development of key therapeutic substances aimed at improving patient outcomes.
Collaborations
Zeng has collaborated with notable individuals in his field, including Jinhua Zhao and Hui Kang. Their teamwork has enabled significant advancements in their respective research areas, illustrating the importance of collaboration in scientific innovation.
Conclusion
Weizhen Zeng's contributions to the field of pharmaceuticals exemplify the impact of dedicated research on developing new treatments for complex health issues. His patents, focused on anticoagulant therapies, mark significant innovative steps forward. As the pharmaceutical industry continues to evolve, Zeng's work serves as a foundation for future advancements.